Baxter Recalls Two Lots of IntraVia

Article

Two lots of empty intravenous fluid bags were voluntarily recalled because of the presence of particulates.

Baxter announced on Oct. 22, 2014 that it was voluntarily recalling two lots of IntraVia containers in the US and Canada because of complaints received of particulate matter found inside the fluid path.

IntraVia containers have PVC ports and a sterile fluid path through which intravenous solution travels. Any particulate matter flowing through these containers could cause serious health consequences, Baxter said in a press release.

Affected lots were distributed to customers between Apr. 26, 2013 and June 20, 2013; and between Nov. 27, 2013 and Mar. 10, 2014. Recalled product can be returned for credit to Baxter, and the company encourages patients and healthcare providers to report any adverse events related to the recall.

Source:
FDA

Recent Videos
Behind the Headlines episode 5
Pharm Tech Group looks at the challenges surrounding the development and manufacture of ATMPs in more detail with Agne Vaitkeviciene, CEO of Memel Biotech.
Pharm Tech Group sits down with Bernard Sagaert, CEO of etherna, to examine the role of mRNA in the treatment of autoimmune diseases.
Related Content
© 2024 MJH Life Sciences

All rights reserved.